Health Headlines: Shifts in Vaccine Policy, Drug Approvals, and Malnutrition Crises
Recent health news highlights include Stada's potential IPO, leadership changes at Gerresheimer, CDC officials resigning over vaccine policy shifts, looming food shortages in four African countries, medical supply shortages in Gaza, UK approving a GSK antibiotic, and FDA approving Teva's generic obesity drug.
German drugmaker Stada is considering an IPO this autumn if conditions are favorable, as per CEO Peter Goldschmidt's statement to dpa. Meanwhile, Gerresheimer's CFO Bernd Metzner has resigned under investor pressure, with Wolf Lehmann due to step in with a private equity background.
Three CDC officials have resigned, expressing concern over newly appointed vaccine advisers possibly influencing policy without thorough data review. In Africa, Save the Children warns of critical shortages in life-saving food for children in Nigeria, Kenya, Somalia, and South Sudan due to aid cuts.
In Gaza, WHO reports a depletion of vital medical supplies as rare Guillain-Barré syndrome cases rise. The UK has approved GSK's new antibiotic for urinary infections, and the US FDA has greenlit Teva Pharmaceuticals' generic obesity drug, impacting the health landscape significantly.
(With inputs from agencies.)
- READ MORE ON:
- Stada
- IPO
- GSK
- antibiotic
- Gerresheimer
- CDC
- vaccine
- malnutrition
- Gaza
- obesity drug
ALSO READ
CDC Leadership Turmoil: Kennedy Shakes Up Health Agency amidst Controversy
Jim O'Neill Takes Reins at CDC Amid Controversies
Shingles Vaccine: A Potential Lifesaver for Heart Health
U.S. Health Shake-Up: Leadership Changes Amid Vaccine Policy Overhaul
Changing COVID Vaccine Coverage: The Fall Impact
Google News